These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17709692)

  • 21. CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
    van Meerten T; Hagenbeek A
    Neth J Med; 2009; 67(7):251-9. PubMed ID: 19687518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extranodal CD20-positive peripheral T-cell lymphoma presenting with adrenal and testicular masses.
    Makita M; Murakami I; Yoshioka T; Tanaka H; Yamamoto K; Imajo K; Takata K; Yoshino T
    Rinsho Ketsueki; 2009 May; 50(5):413-8. PubMed ID: 19483402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas.
    Chuang SS; Chang ST; Chuang WY; Huang WT; Hsieh PP; Tsou MH; Liao YL; Lin SH; Hsieh YC; Lu CL; Sheu MJ; Liu H
    Am J Surg Pathol; 2009 Aug; 33(8):1230-40. PubMed ID: 19561449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rituximab resistance in B-cell lymphoma and its elimination].
    Hatake K; Terui Y
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):548-51. PubMed ID: 19381025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
    Gobbi G; Mirandola P; Malinverno C; Sponzilli I; Carubbi C; Ricci F; Binazzi R; Basso G; Giuliani-Piccari G; Ramazzotti G; Pasquantonio G; Cocco L; Vitale M
    Int J Oncol; 2008 Aug; 33(2):371-4. PubMed ID: 18636158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literature.
    Grigoriadis G; Gilbertson M; Came N; Westerman D; Fellepa F; Jene N; Chapple P; Juneja S
    Pathology; 2012 Oct; 44(6):552-6. PubMed ID: 22935987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas.
    Stacchini A; Demurtas A; Aliberti S; Francia di Celle P; Godio L; Palestro G; Novero D
    Am J Clin Pathol; 2007 Nov; 128(5):854-64. PubMed ID: 17951210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels.
    Czuczman MS; Olejniczak S; Gowda A; Kotowski A; Binder A; Kaur H; Knight J; Starostik P; Deans J; Hernandez-Ilizaliturri FJ
    Clin Cancer Res; 2008 Mar; 14(5):1561-70. PubMed ID: 18316581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse large B-cell lymphomas and burkitt lymphoma.
    de Leval L; Hasserjian RP
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):791-827. PubMed ID: 19577170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG ODN enhances the efficacy of rituximab in non-Hodgkin lymphoma.
    Buhé V; Guerrier T; Youinou P; Berthou C; Loisel S
    Ann N Y Acad Sci; 2009 Sep; 1173():858-64. PubMed ID: 19758238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive use.
    Benetatos L; Dova L; Baxevanos G; Kolaitis NI; Bourantas KL; Vartholomatos G
    Cytometry B Clin Cytom; 2009 Mar; 76(2):102-6. PubMed ID: 18956469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma.
    Beltran B; Quiñones P; Morales D; Cotrina E; Castillo JJ
    Leuk Res; 2011 Mar; 35(3):334-9. PubMed ID: 20828817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD3-positive large B-cell lymphoma.
    Wang J; Chen C; Lau S; Raghavan RI; Rowsell EH; Said J; Weiss LM; Huang Q
    Am J Surg Pathol; 2009 Apr; 33(4):505-12. PubMed ID: 19011566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
    Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
    Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses to rituximab vary among follicular lymphoma B cells of different maturation stages.
    Mattila AM; Meri S
    Scand J Immunol; 2008 Aug; 68(2):159-68. PubMed ID: 18702746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
    Roll P; Dörner T; Tony HP
    Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.
    Sar A; Perizzolo M; Stewart D; Mansoor A; Difrancesco LM; Demetrick DJ
    Leuk Res; 2009 Jun; 33(6):792-7. PubMed ID: 19054557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells.
    Hayden-Ledbetter MS; Cerveny CG; Espling E; Brady WA; Grosmaire LS; Tan P; Bader R; Slater S; Nilsson CA; Barone DS; Simon A; Bradley C; Thompson PA; Wahl AF; Ledbetter JA
    Clin Cancer Res; 2009 Apr; 15(8):2739-46. PubMed ID: 19351771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.